| 摘要: |
| 完全植入式静脉输液港(TIVAP)是一种由钛制成的皮下植入端口,连接硅胶中央静脉导管,为静脉注射化疗药物和液体提供了一种简单、安全的进入血管系统的方法。1982 年美国安德森癌症中心Niederhuber 等首次提出并开展TIVAP,其长期留置、便于管理、低感染率等优势被临床接受。尽管如此,TIVAP仍然无法避免相关早期及晚期并发症的发生,其中输液港相关感染作为最常见并发症,不仅会增加患者费用,还会增加患者发病率及病死率。因此,正确预防和治疗输液港感染对儿童肿瘤患者有重要意义。本综述总结儿童TIVAP的高危因素,就目前的防治进展进行阐述,为临床提供参考。 |
| 关键词: |
| DOI：10.13407/j.cnki.jpp.1672-108X.2021.02.019 |
|
| 基金项目: |
|
| Process of Prevention and Treatment for Infection of Totally Implantable Venous Access Port in Children |
| Zhuo Xiaoyu1, Su Yongchun2, Xiao Jianwen1 |
| (1. Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Department and Disorders, Chongqing Key Laboratory of Pediatrics, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing 400014, China; 2. Chongqing Yasin Children’s Hospital, Chongqing 400700, China) |
| Abstract: |
|
| Key words: |
